CRO Support for Drug Substance Development and Manufacture (2017) | Federal Compass

Free Market Report: Trends & Observations
CRO Support for Drug Substance Development and Manufacture (2017)


Prepare yourself for competition by understanding federal market trends. Is this the right pursuit for my organization? How is the government buying my product and services? Is there an upcoming recompete for future work?


Contracting Agency/Office
Health and Human Services » National Institutes of Health » National Institute on Drug Abuse
NAICS
325411 Medicinal and Botanical Manufacturing
Competition Set-Aside Type
NONE

Award Type
IDC
Award Date
03/30/2017
Expiration Date
03/30/2022
No. of Awards
8
No. of Offers
10

Obligations by Fiscal Year

prime obligations by fiscal year, trending at 212.99% CAGR

Download the Full Report Today
Trends & Observations: CRO Support for Drug Substance Development and Manufacture (2017)

The full contract vehicle assessment includes:
Preference Program Trends
Set Aside Preference
Key Buyers
Buying Trends & Activity
Funding Account Health
Task Order Activity
Small Business Trends
Contractor Performance
Potential Recompete Opportunities

If you do business with the Federal Government, you need Federal Compass.

We are a public sector market intelligence and solutions platform for government contracting.

Contracting Resources